Preimplantation genetic diagnosis liberalised in Germany before 2027?
One-OffSalute e medicinaScienzaRegolamentazioneEuropa2mManifold MarketsSenza KYCDati di risoluzione verificatiDiscretamente calibratoAvviso sulla qualità dei datiDati della fonte degradati
Dati al 24 ott 2026, 21:40 UTC · criterio pm-quality-4
Previsione della comunità attualeNo 90.9%
Previsori
13
Tipo di domanda
binary
Metodologia
Play-money forecasting platform
Tipo di fonte
Previsione
Dati di mercato
Aggiornato 1 ora fa
In ritardo3 lug 25, 16:03 UTC31 dic 26, 23:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Will Congress ban the sale of USA citizen genetic information to foreign companies or organizations by end of 2026?
Manifold MarketsWill the US, UK or EU approve a gene editing therapy for a new condition during 2026?
FutuurEpstein-Barr virus vaccine by 2032?
Manifold MarketsThere will be more children born via artificial wombs than not in first world countries before 2050
Manifold Markets[ACX 2026] Will the US, UK or EU approve a gene editing therapy for a new condition during 2026?
Manifold MarketsWill the North Atlantic Current collapse before 2030?
Manifold MarketsRegole
Preimplantation genetic diagnosis (PGD) is currently permitted in Germany under specific conditions, primarily to prevent severe hereditary diseases.
- This market assesses whether PGD will become more broadly available in Germany by December 31, 2026.
- Resolution will be based on official announcements from the German Federal Ministry of Health or reputable news sources confirming expanded access to PGD services.
